|Bid||82.00 x 400|
|Ask||86.74 x 500|
|Day's Range||85.38 - 86.78|
|52 Week Range||53.78 - 104.71|
|PE Ratio (TTM)||14.68|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Masimo Corp. a score of 88. Our analysis is based on comparing Masimo Corp. with the following peers – ResMed Inc., Royal Philips NV Sponsored ADR, Thermo Fisher Scientific Inc., Natus Medical Incorporated, Owens & Minor, Inc., Cardinal Health, Inc., Universal Forest Products, Inc., CAS Medical Systems, ... Read more (Read more...)
McKesson (MCK) entered fiscal 2018 with an assumption of branded inflation in the mid-single digits. Pricing pressure in the independent retail pharmacy channel is a headwind.
BioTelemetry (BEAT) is putting efforts in product innovation through research and development. The company recently announced the acquisition of LifeWatch AG in a deal valued at about $280 million.